haloperidol has been researched along with Nocturnal Wandering in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These episodes are differentiated from nocturnal wanderings and epileptic attacks during sleep; they occurred within two to three hours after sleep onset and were characterized by the patients appearing confused and walking about in a quiet, detached and clumsy manner." | 1.26 | Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. ( Charney, DS; Kales, A; Nelson, JC; Soldatos, CR, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charney, DS | 1 |
| Kales, A | 1 |
| Soldatos, CR | 1 |
| Nelson, JC | 1 |
1 other study available for haloperidol and Nocturnal Wandering
| Article | Year |
|---|---|
Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Drug Therapy, Combination | 1979 |